Retinal Cell Aggregate Using Extracellular Matrix for Engraftment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing retinal tissue containing both neural retina and retinal pigment epithelial cells for transplantation fail to achieve correct localization and long-term engraftment due to poor adhesion of cells, leading to ineffective tissue formation and function.
Innovation Solution
A sphere-like cell aggregate is developed, comprising a core part with a neural retinal layer and a covering part of retinal pigment epithelial cells, where the cells are adhered using an extracellular matrix, enabling the formation of a structure similar to native retinal tissue, with the retinal pigment epithelial cells covering at least a portion of the neural retina surface.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If a cell mixture of retinal progenitor cells and RPE cells is used for transplantation, then both cell types are provided in the graft, but the cells are not adhered to each other and long-term engraftment is poor
Solution Approach 1:
The patent introduces an extracellular matrix as an intermediary substance between retinal progenitor cells and RPE cells. This matrix serves as a mediator that facilitates adhesion between the two cell types, enabling them to attach to each other and form a stable, integrated tissue structure capable of long-term engraftment in the host retina.
Solution Approach 2:
The patent applies preliminary action by pre-coating the transplantation graft with extracellular matrix before implantation. This preliminary treatment ensures that the retinal progenitor cells and RPE cells are pre-equipped with adhesion capabilities, allowing them to immediately attach to the host retina upon transplantation and establishing long-term engraftment from the outset.
2Reliability
If retinal progenitor cells are adhered to an RPE cell sheet, then cell adhesion is achieved, but the retinal progenitor cells are not closely adhered to each other and cannot function as retinal tissue
Solution Approach 1:
The patent merges retinal progenitor cells with RPE cells through a common extracellular matrix framework. This merging process allows both cell types to adhere to the same matrix substrate, enabling them to form a closely integrated tissue structure where cells are not only attached to the RPE layer but also closely adhered to each other, achieving both adhesion and proper tissue organization.
Solution Approach 2:
The patent applies local quality by providing extracellular matrix at specific locations where cell adhesion is needed. The matrix is strategically positioned to enable retinal progenitor cells to adhere to RPE cells at the interface, while also allowing close adhesion between adjacent retinal progenitor cells, thereby creating locally optimized conditions for both adhesion and tissue structure formation.
3Ease of manufacture
If neural retina and RPE cells are transplanted separately, then each cell type can be optimized independently, but correct localization and directional arrangement as in native retinal tissue cannot be achieved
Solution Approach 1:
The extracellular matrix serves as an intermediary framework that guides the spatial organization of independently prepared neural retina and RPE cells. By providing a common adhesive substrate, the matrix enables these separately optimized cell populations to self-organize into the correct localized positions and directional arrangements that mimic native retinal tissue architecture upon transplantation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The sphere-like cell aggregate allows for successful long-term engraftment and functional integration of transplanted cells, improving visual function by replicating the native retinal tissue structure and promoting photoreceptive and protective functions.
Implementation Method 1
the cells are adhered using an extracellular matrix
Data Source
AI summary
A sphere-like cell aggregate according to one embodiment of the present invention comprises: a core part containing neural retina; and a covering part continuously or discontinuously covering at least a portion of a surface of the core part.